Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...

Lilly is testing bimagrumab alone and in combination with Novo's Wegovy -- a mid-stage trial begun before the acquisition -- ...

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

A high-profile medical blunder is earning a man from the US state of New Mexico a whopping €400 million in damages. He ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

ALBAWABA - The popular weight loss drug, Ozempic is causing panic among its users after experts revealed an alarming side ...

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.